The treatment of Anemia & Backache with vitamins

Anemia and Backache: Mitamins custom make quality formulas for the treatment of Anemia & Backache with vitamins. A Anemia & Backache formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Anemia and Backache

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Folate
    800
    mcg
    200%
    Vitamin B12
    1000
    mcg
    16667%
    Calcium
    50
    mg
    5%
    Iron
    9
    mg
    50%
    Magnesium
    25
    mg
    6%
    Potassium
    50
    mg
    1%
  • Amount Per Serving
    % DV
    Feverfew Extract
    50
    mg
    *
    DL-Phenylalanine
    100
    mg
    *
    Yellow Dock Extract
    100
    mg
    *
    Dandelion Extract
    100
    mg
    *
    White Willow Extract
    30
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Anemia and Backache Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Work Time Predicts Sleep Time (HealthDay)
The more hours adults work and the more hours they spend commuting to the job, the less time they spend sleeping.
King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
Palatin Technologies, Inc. (Amex: PTN) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that they have delayed plans for the initiation of Phase 3 clinical trials with bremelanotide, a first in class melanocortin agonist drug candidate, for the treatment of male erectile dysfunction (ED). The decision follows responses from representatives of the U.S.
This information concerning the support of Anemia and Backache treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments